| 000 | 01698 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513194102.0 | ||
| 264 | 0 | _c19991103 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.53.7.1402 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrojano, M | |
| 245 | 0 | 0 |
_aChanges of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS. _h[electronic resource] |
| 260 |
_bNeurology _cOct 1999 |
||
| 300 |
_a1402-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies _xanalysis |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGadolinium |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xblood |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 | _aInterferon beta-1b |
| 650 | 0 | 4 |
_aInterferon-beta _ximmunology |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xblood |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xblood |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xblood |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSolubility |
| 700 | 1 | _aAvolio, C | |
| 700 | 1 | _aLiuzzi, G M | |
| 700 | 1 | _aRuggieri, M | |
| 700 | 1 | _aDefazio, G | |
| 700 | 1 | _aLiguori, M | |
| 700 | 1 | _aSantacroce, M P | |
| 700 | 1 | _aPaolicelli, D | |
| 700 | 1 | _aGiuliani, F | |
| 700 | 1 | _aRiccio, P | |
| 700 | 1 | _aLivrea, P | |
| 773 | 0 |
_tNeurology _gvol. 53 _gno. 7 _gp. 1402-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.53.7.1402 _zAvailable from publisher's website |
| 999 |
_c10491152 _d10491152 |
||